Scintillating nanotubes for the treatment of the Alzheimer disease
Protein misfolding and aggregation are the fundamental causes of many degenerative conditions, including Alzheimer’s and Parkinson’s disease (AD and PD) as well as type II diabetes. Misfolded proteins are usually biologically inactive; however, the dynamic equilibrium between monomeric and oligomeric aggregates may lead to cytotoxic states that induce the degenerative condition. In AD, amyloid-β (Aβ) and tau proteins misfold and form oligomers and fibrils that accumulate in the brain in pathogenic pathways leading to synaptic loss and selective neuronal cell death.